載入...
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality of PTZ vs carbapenems as empiric therapy in a cohort of patients with ESBL bacteremia who all received definitive therapy...
Na minha lista:
| 發表在: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462658/ https://ncbi.nlm.nih.gov/pubmed/25586681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|